rVSV

A recombinant vesicular stomatitis virus-based vaccine platform; the technology behind Ervebo, the licensed Zaire ebolavirus vaccine, now in use for a Bundibugyo ebolavirus candidate six to nine months from trial doses.

1 of 1 entries (1 events, 0 interactions)